Composition comprising metadoxine for preventing or treating obesity

The present invention relates to a composition for the prevention or treatment of obesity or its complications containing metadoxin (pyridoxol L-2-pyrrolidone-5-carboxylate, metadoxine) as an active ingredient, and to the prevention or treatment of obesity or its complications using the same It is about. Metadoxin, obesity treatment, pharmaceutical composition